Vincerx Pharma Stock Current Valuation
| VINC Stock | USD 0.65 0.03 4.84% |
Valuation analysis of Vincerx Pharma helps investors to measure Vincerx Pharma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value Over EBITDA is expected to grow to -12.62. The current year's Enterprise Value Multiple is expected to grow to -12.62. Fundamental drivers impacting Vincerx Pharma's valuation include:
Overvalued
Today
Please note that Vincerx Pharma's price fluctuation is out of control at this time. Calculation of the real value of Vincerx Pharma is based on 3 months time horizon. Increasing Vincerx Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Vincerx Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vincerx Stock. However, Vincerx Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.65 | Real 0.62 | Target 6.0 | Hype 0.65 | Naive 1.05 |
The real value of Vincerx Stock, also known as its intrinsic value, is the underlying worth of Vincerx Pharma Company, which is reflected in its stock price. It is based on Vincerx Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Vincerx Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Vincerx Pharma helps investors to forecast how Vincerx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vincerx Pharma more accurately as focusing exclusively on Vincerx Pharma's fundamentals will not take into account other important factors: Vincerx Pharma Company Current Valuation Analysis
Vincerx Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Vincerx Pharma Current Valuation | (7.01 M) |
Most of Vincerx Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vincerx Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vincerx Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Vincerx Pharma is extremely important. It helps to project a fair market value of Vincerx Stock properly, considering its historical fundamentals such as Current Valuation. Since Vincerx Pharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vincerx Pharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vincerx Pharma's interrelated accounts and indicators.
Click cells to compare fundamentals
Vincerx Current Valuation Historical Pattern
Today, most investors in Vincerx Pharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Vincerx Pharma's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Vincerx Pharma current valuation as a starting point in their analysis.
Vincerx Pharma Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Vincerx Pharma has a Current Valuation of (7.01 Million). This is 100.05% lower than that of the Biotechnology sector and 100.15% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.04% higher than that of the company.
Vincerx Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vincerx Pharma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vincerx Pharma could also be used in its relative valuation, which is a method of valuing Vincerx Pharma by comparing valuation metrics of similar companies.Vincerx Pharma is currently under evaluation in current valuation category among its peers.
Vincerx Fundamentals
| Return On Equity | -1.42 | ||||
| Return On Asset | -0.66 | ||||
| Current Valuation | (7.01 M) | ||||
| Shares Outstanding | 30.88 M | ||||
| Shares Owned By Insiders | 18.06 % | ||||
| Shares Owned By Institutions | 36.00 % | ||||
| Number Of Shares Shorted | 108.52 K | ||||
| Price To Book | 0.16 X | ||||
| EBITDA | (42.61 M) | ||||
| Net Income | (40.16 M) | ||||
| Cash And Equivalents | 80.86 M | ||||
| Cash Per Share | 3.82 X | ||||
| Total Debt | 2.5 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 7.88 X | ||||
| Book Value Per Share | 0.52 X | ||||
| Cash Flow From Operations | (40.45 M) | ||||
| Short Ratio | 0.80 X | ||||
| Earnings Per Share | (1.14) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 42 | ||||
| Beta | 1.27 | ||||
| Market Capitalization | 10.48 M | ||||
| Total Asset | 18.22 M | ||||
| Retained Earnings | (159.11 M) | ||||
| Working Capital | 9.13 M | ||||
| Net Asset | 18.22 M |
About Vincerx Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vincerx Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vincerx Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vincerx Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Vincerx Pharma Piotroski F Score and Vincerx Pharma Altman Z Score analysis. For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vincerx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vincerx Pharma is measured differently than its book value, which is the value of Vincerx that is recorded on the company's balance sheet. Investors also form their own opinion of Vincerx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Vincerx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vincerx Pharma's market value can be influenced by many factors that don't directly affect Vincerx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vincerx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.